KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $0.0748 $0.0748 Thursday, 25th Apr 2024 BLCM stock ended at $0.0748. During the day the stock fluctuated 0% from a day low at $0.0748 to a day high of $0.0748.
90 days $0.0650 $0.110
52 weeks $0.0600 $1.31

Historical Bellicum Pharmaceuticals prices

Date Open High Low Close Volume
Aug 15, 2023 $0.480 $0.490 $0.475 $0.485 25 599
Aug 14, 2023 $0.475 $0.485 $0.475 $0.480 3 904
Aug 11, 2023 $0.470 $0.478 $0.470 $0.475 24 039
Aug 10, 2023 $0.470 $0.479 $0.470 $0.479 10 861
Aug 09, 2023 $0.470 $0.475 $0.470 $0.475 7 771
Aug 08, 2023 $0.461 $0.479 $0.460 $0.470 42 394
Aug 07, 2023 $0.461 $0.466 $0.450 $0.461 26 934
Aug 04, 2023 $0.450 $0.462 $0.450 $0.456 20 735
Aug 03, 2023 $0.482 $0.482 $0.450 $0.450 1 046
Aug 02, 2023 $0.430 $0.462 $0.430 $0.450 22 395
Aug 01, 2023 $0.430 $0.437 $0.430 $0.430 5 581
Jul 31, 2023 $0.445 $0.452 $0.430 $0.430 17 283
Jul 28, 2023 $0.430 $0.460 $0.430 $0.460 17 145
Jul 27, 2023 $0.420 $0.450 $0.400 $0.430 164 641
Jul 26, 2023 $0.402 $0.432 $0.400 $0.432 24 230
Jul 25, 2023 $0.380 $0.425 $0.380 $0.425 15 428
Jul 24, 2023 $0.384 $0.400 $0.370 $0.380 59 696
Jul 21, 2023 $0.380 $0.385 $0.380 $0.385 7 800
Jul 20, 2023 $0.380 $0.383 $0.380 $0.381 11 301
Jul 19, 2023 $0.380 $0.390 $0.380 $0.380 22 023
Jul 18, 2023 $0.370 $0.385 $0.370 $0.380 128 858
Jul 17, 2023 $0.371 $0.375 $0.370 $0.375 34 237
Jul 14, 2023 $0.375 $0.380 $0.374 $0.374 3 892
Jul 13, 2023 $0.370 $0.379 $0.370 $0.370 15 021
Jul 12, 2023 $0.370 $0.376 $0.370 $0.376 12 285
Click to get the best stock tips daily for free!

About Bellicum Pharmaceuticals

Bellicum Pharmaceuticals Bellicum Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers and solid tumors in the United States and internationally. The company's clinical product candidates include BPX-601, an autologous GoCAR-T product candidate, which is in Phase 1/2 clinical trials for the treatment of solid tumors expressing the prostate stem ce... BLCM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT